COVID-19 potential drug remdesivir priced at $2,340 for a patient in US
Gilead Sciences Inc priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed…
Browsing Tag
Gilead Sciences
Gilead to begin human trials of inhaled version of remdesivir, potential COVID-19 drug
Gilead Sciences received approval from the U.S. Food and Drug Association to begin trials of an easier to…
Gilead says to start testing remdesivir in children
Gilead Sciences Inc, which makes the antiviral drug remdesivir and is now testing it for potential coronavirus…
Egypt’s drug maker, Eva Pharma to manufacture Gilead’s remdesivir for…
Egypt-based Eva Pharma has signed a deal with Gilead Sciences for manufacturing and sale of remdesivir, which has…
Gilead’s Remdesivir study on monkeys shows drug reduced lung damage linked to coronavirus
Gilead Sciences’ antiviral drug remdesivir has helped to prevent macaques infected with the coronavirus from…
Remdesivir helped moderate coronavirus patients improve: Gilead
Gilead Sciences Inc said that its antiviral drug remdesivir showed improvement in patients with moderate COVID-19…
Gilead licences drugmakers to make remdesivir coronavirus treatment in 127 countries
Gilead Sciences has signed a licencing agreement with five generic drugmakers to make antiviral drug remdesivir in…
WHO to talk with U.S., Gilead to make coronavirus potential drug remdesivir more widely…
The World Health Organisation (WHO) is planning to speak with the U.S. government and biotech firm Gilead Sciences …
Gilead says remdesivir coronavirus treatment will need a ‘sustainable model’ to keep it…
Gilead Sciences is doing its best to make experimental antiviral drug remdesivir accessible and affordable to…
Gilead to produce ‘several million’ rounds of remdesivir to help treat coronavirus…
Gilead Sciences said on Thursday that it can produce “several million” rounds of its antiviral drug remdesivir in…
